This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arch Capital (ACGL) Estimates Q1 Catastrophe Loss of $180-$190M
by Zacks Equity Research
Arch Capital (ACGL) estimates cat loss of $180-$190 million for the first quarter of 2021 due to exposure to the COVID-19 pandemic, and North American winter storms Uri and Viola.
Winter Storm Uri to Dampen RenaissanceRe's (RNR) Q1 Results
by Zacks Equity Research
RenaissanceRe (RNR) projects net negative impact of around $180 million on first-quarter 2021 results stemming from incidence of Winter Storm Uri.
Why Should You Retain RenaissanceRe (RNR) in Your Portfolio?
by Zacks Equity Research
Riding high on balance sheet strength and rising premiums, RenaissanceRe (RNR) holds potential to reap benefits for investors.
Horace Mann (HMN) to Reward Shareholders With 3% Dividend Hike
by Zacks Equity Research
Horace Mann's (HMN) recent dividend hike reflects solid financial foundation and operational performance.
FBL Financial (FFG) to Share More Profits, Ups Dividend by 4%
by Zacks Equity Research
FBL Financial's (FFG) recent dividend hike reflects solid financial foundation and operational performance generating excess capital.
Chubb (CB) Board Looks to Recommend Dividend Hike of 2.6%
by Zacks Equity Research
Chubb (CB) board to propose dividend hike of 2.6% to share more profits with shareholders, thereby supporting effective capital deployment.
Allstate (ALL) Rewards Shareholders With 50% Dividend Hike
by Zacks Equity Research
Allstate's (ALL) recent dividend hike is indicative of the company's robust financial standing and commitment to enhance shareholders' value.
RenaissanceRe (RNR) Raises Dividend to Reward Shareholders
by Zacks Equity Research
RenaissanceRe's (RNR) recent dividend hike indicates strong financial standing and prudent efforts to enhance shareholders' value.
RenaissanceRe (RNR) Q4 Loss Lower Than Expected, Worsens Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter earnings take a hit from higher costs and weak net investment income.
Arch Capital (ACGL) Guides Q4 Catastrophe Loss of $155-$165M
by Zacks Equity Research
Arch Capital (ACGL) estimates cat loss of $155-$165 million for the fourth quarter due to exposure to COVID-19 pandemic, hurricanes Delta and Zeta and other minor global events.
AXIS Capital (AXS) Estimates Q4 Catastrophe Loss of $195-$205M
by Zacks Equity Research
AXIS Capital (AXS) estimates fourth-quarter catastrophe loss in the range of $195-$205 million due to exposure to COVID-19 pandemic, Hurricanes Zeta and Delta.
High Cat Loss to Hurt RenaissanceRe's (RNR) Underwriting Results
by Zacks Equity Research
RenaissanceRe (RNR) expects net negative impact of around $170 million on fourth-quarter 2020 results due to persistent occurrence of catastrophe events.
Here's Why You Should Stay Away From RenaissanceRe (RNR) Now
by Zacks Equity Research
Exposure to severe cat loss and rising expenses make RenaissanceRe (RNR) an unattractive bet.
RenaissanceRe's (RNR) Q3 Loss Wider Than Expected, Worsens Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) third-quarter earnings take a hit from higher costs and weak net investment income.
High Cat Loss to Dent RenaissanceRe's Underwriting Margins
by Zacks Equity Research
RenaissanceRe (RNR) anticipates net negative impact of around $325 million on third-quarter 2020 results due to incidence of consecutive catastrophe events.
Why Should You Retain RenaissanceRe (RNR) in Your Portfolio?
by Zacks Equity Research
Banking on rising premiums and a solid balance sheet position, RenaissanceRe (RNR) holds potential to reap benefits for investors.
Hurricane Laura-Led Uncertainty Brings Insurers in Focus
by Tanuka De
As Hurricane Laura wreaks havoc, we focus on a few insurers and reinsurers to see how they may be impacted.
RenaissanceRe (RNR) Down 0.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Everest Re or RenaissanceRe: Which P&C Insurer Has an Edge?
by Zacks Equity Research
Let's see how Everest Re (RE) and RenaissanceRe (RNR) fare in terms of some of the key metrics.
RenaissanceRe's (RNR) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) Q2 results reflect higher revenues and solid segmental contributions.
Why Is RenaissanceRe (RNR) Up 30.6% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A.M. Best Dubs Insurance Industry as Strongly Capitalized Space
by Sapna Bagaria
Insurers' capital looks strong enough to overcome potential losses from COVID-19 as well as the forthcoming hurricane season
RenaissanceRe's (RNR) Q1 Earnings Miss Estimates, Drop Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) Q1 results reflect the adversity of the coronavirus outbreak and its escalating expenses.
Insurance Stock Q1 Earnings Due on May 6: MET, RE & More
by Tanuka De
Insurers in the first quarter are likely to have suffered from low interest rates and charges from the COVID-19 impact but benefited from strong top lines driven by their vast and diversified businesses.
Here's Why You Should Add RenaissanceRe to Your Portfolio
by Zacks Equity Research
RenaissanceRe (RNR) holds potential to provide benefits to investors on the back of its growing premiums and financial strength.